UNI-MB - logo
UMNIK - logo
 
E-viri
Preverite dostopnost
Recenzirano
  • Feng, Jianhua; Leung, Alex W K; Cheng, Frankie W T; Lam, Grace K S; Chow, Terry T W; Ng, Margaret H L; Chu, Winnie C W; Chan, Natalie P H; Li, Chi-Kong

    Journal of pediatric hematology/oncology, 2021-Nov-01, Letnik: 43, Številka: 8
    Journal Article

    There is no established effective treatment for patients with t(1;22)(p13;q13) acute megakaryoblastic leukemia (AMKL) and hepatic fibrosis. Here we report the outcomes of 2 t(1;22)(p13;q13) AMKL patients with hepatic fibrosis. One patient died from liver failure despite the control of leukemia. The other patient was successfully treated with reduced-intensity chemotherapy and antifibrosis therapy with tretinoin and α-tocopheryl acetate, the hepatic fibrosis resolved and leukemia was in remission for 3 years. Reduced-intensity chemotherapy plus antifibrosis therapy with tretinoin and α-tocopheryl acetate could be a treatment option for these patients with t(1;22)(p13;q13) AMKL and hepatic fibrosis.